Munar Pharma S.A.

zł 0.30As of Sun 8 Nov 2026, 12:00 UTC
WSE:MUN—
Country Poland
PE (Fwd) •••
TSR 10Y CAGR 0.48%
Div yield —
ROE —
Computer Programming, Data Processing, And Other Computer Related Services
Beta (5Y) 0.37
PE TTM —
TSR TTM (33.33%)
Mkt cap zł 13.90M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 0.367
23.94%
22.77%
Hold 3|8|1|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
—
—
—
0.01
19.51%
19.58%
27.22%
20.31%
Revenuezł M
0.962
0.937
0.963
0.976
2.98%
2.56%
2.68%
3.74%
Peers (US$3.511M)
Cap (US$)
PE
3.376M
—
1.609M
—
Capital
TTM
5Y
10Y
Leveragex
1.393
(0.191)
(0.164)
EBIT/Intx
0.336
0.484
0.459
Own earn%
20.35
7.18
6.14
Sh yield%
50.93
42.62
42.52
Owners
Insiders/Inst%
7.69
85.98
Short interest%
5.20
SBC / revenue%
4.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
24